CTOs on the Move

QLT Inc

www.qltinc.com

 
QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT`s head office is based in Vancouver, Canada and the company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT).
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.qltinc.com
  • 887 Great Northern Way Suite 250
    Vancouver, BC CAN V5T 4T5
  • Phone: 604.707.7000

Executives

Name Title Contact Details

Similar Companies

Alyvant

Using data to connect patients to therapies that better benefit them.

ErgoSuture

Ergosuture - wound closure, enhanced suturing devices

Akari Therapeutics

Akari Therapeutics is a clinical stage biopharmaceutical company focused on developing and commercializing treatments for rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5). Its lead drug, Covers...

MHC Healthcare

MHC Healthcare is a network of health centers focused on serving the communities where our patients live. We promote and support accessible and affordable primary health care services for all individuals independent of socio-economic status, national o...

Vincerx

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.